Results 111 to 120 of about 18,063 (229)

Radioprotective Efficacy of Cysteamine [PDF]

Acta Radiologica: Therapy, Physics, Biology, 1964
A, BOSE, S, BOSE, P, DE
openaire   +2 more sources

Comparison between the efficacy of cysteamine cream and combined hydroquinone cream in the treatment of melasma using skin analytical systems: An open-label quasi-randomized controlled trial in Asia patients

Dermatologica Sinica
Background: The mainstay of treatment for melasma is topical hydroquinone or preparations containing hydroquinone. In recent years, cysteamine cream has gained popularity in the treatment of hyperpigmentation disorders.
Andy Deng-Chi Chuang, Erh-Ti Lin, Chang-Cheng Chang, Yung-Hsueh Huang, Meng-En Lu, Chun-Fang Chuang, Hsiu-Mei Chiang   +6 more
doaj   +1 more source

Improving the prognosis of nephropathic cystinosis

International Journal of Nephrology and Renovascular Disease, 2014
Martine TP Besouw,1,2 Elena N Levtchenko1,21Department of Pediatric Nephrology, University Hospitals Leuven, Belgium; 2Laboratory of Pediatrics, Catholic University Leuven, Leuven, BelgiumAbstract: Cystinosis is an autosomal recessive inherited lysosomal
Besouw MTP, Levtchenko EN
doaj  

Efficacy and safety of cysteamine in the treatment of melasma: a systematic review and meta-analysis of randomized controlled trials

Journal of the Egyptian Women’s Dermatologic Society
Melasma is a persistent and recurrent pigmentation disorder that significantly impacts patients’ quality of life and presents challenges in management with conventional treatments.
Monica Trifitriana, Yuli Kurniawati, Fatima A. Khairani   +2 more
doaj   +1 more source

Mitigative role of cysteamine against unilateral renal reperfusion injury in Wistar rats

Frontiers in Pharmacology
BackgroundIschemia-reperfusion injury (IRI) is unavoidable during kidney transplant and it is responsible for delayed or non-function after kidney transplantation. Cysteamine is the standard drug in the management of nephropathic cystinosis and its extra-
Babatunde Adebola Alabi, Babatunde Adebola Alabi, Okot-Asi Nku-Ekpang, Sodiq Kolawole Lawal, Ezekiel Olugbenga Iwalewa, Temidayo Omobowale, Richard Ajike, Ridwan Abiodun Lawal   +7 more
doaj   +1 more source

Therapeutic strategies in cystinosis: A focus on cysteamine and beyond

Experimental and Molecular Pathology
Cystinosis is a autosomal recessive lysosomal storage disorder caused by mutations in the CTNS gene, which encodes cystinosin, a cystine transporter.
Angelo Santoro, Yuri Vincenzo Ferrara, Alfonso De Angelis   +2 more
doaj   +1 more source

_In vivo_ photoacoustic molecular imaging with simultaneous multiple selective targeting using antibody-conjugated gold nanorods [PDF]

, 2008
The use of gold nanorods for photoacoustic molecular imaging in vivo with simultaneous multiple selective targeting is reported. The extravasation of multiple molecular probes is demonstrated, and used to probe molecular information of cancer cells. This
Ann-Ann Ding, Carolina Poe, Chao-Kang Liao, Chen-Wei Wei, Churng-Ren Wang, Dar-Bin Shieh, Pai-Chi Li, Suwen Jhan, Ya-Na Wu   +8 more
core   +1 more source

Mediator-free total cholesterol estimation using a bi-enzyme functionalized nanostructured gold electrode [PDF]

, 2015
We report the fabrication of a bi-enzyme functionalized nanostructured Au electrode for the mediator-free determination of total cholesterol. A one-step electrochemical route for the synthesis, functionalization and deposition of Au nanostructures via ...
Agrawal, Ved Varun, Sharma, Rachna, Sinha, R. K.   +2 more
core  

Toxicity studies of combination of silver nanoparticles and cryogels [PDF]

, 2014
The combination "cryogel + nanoparticles" allows developing a new type of wound dressing, where antimicrobial properties of silver nanoparticles made have been utilized.
Akhmetova, A., Illsley, M., Mikhalovsky, S. V., Nurgozhin, T., Saliev, T.   +4 more
core  

A Synthetic Model of the Nonheme Iron–Superoxo Intermediate of Cysteine Dioxygenase [PDF]

, 2018
A nonheme Fe(II) complex (1) that models substrate-bound cysteine dioxygenase (CDO) reacts with O2 at −80 °C to yield a purple intermediate (2). Analysis with spectroscopic and computational methods determined that 2 features a thiolate-ligated Fe(III ...
Fiedler, Adam T., Fischer, Anne A., Lindeman, Sergey V.   +2 more
core   +1 more source